BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 15199134)

  • 21. SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.
    Zhang H; Chen Z; Ye Y; Ye Z; Cao D; Xiong Y; Srivastava M; Feng X; Tang M; Wang C; Tainer JA; Chen J
    Nucleic Acids Res; 2019 Nov; 47(19):10181-10201. PubMed ID: 31495888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gamma-H2AX formation in response to interstrand crosslinks requires XPF in human cells.
    Mogi S; Oh DH
    DNA Repair (Amst); 2006 Jun; 5(6):731-40. PubMed ID: 16678501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.
    Melton DW; Ketchen AM; Núñez F; Bonatti-Abbondandolo S; Abbondandolo A; Squires S; Johnson RT
    J Cell Sci; 1998 Feb; 111 ( Pt 3)():395-404. PubMed ID: 9427687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses.
    Perez-Oliva AB; Lachaud C; Szyniarowski P; Muñoz I; Macartney T; Hickson I; Rouse J; Alessi DR
    EMBO J; 2015 Feb; 34(3):326-43. PubMed ID: 25538220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair.
    Rahn JJ; Adair GM; Nairn RS
    Environ Mol Mutagen; 2010 Jul; 51(6):567-81. PubMed ID: 20658648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
    Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
    Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
    Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
    Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of varying gene targeting parameters on processing of recombination intermediates by ERCC1-XPF.
    Rahn JJ; Rowley B; Lowery MP; Coletta LD; Limanni T; Nairn RS; Adair GM
    DNA Repair (Amst); 2011 Feb; 10(2):188-98. PubMed ID: 21123118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure-specific endonuclease complex SLX4-XPF regulates Tus-Ter-induced homologous recombination.
    Elango R; Panday A; Lach FP; Willis NA; Nicholson K; Duffey EE; Smogorzewska A; Scully R
    Nat Struct Mol Biol; 2022 Aug; 29(8):801-812. PubMed ID: 35941380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function and Interactions of ERCC1-XPF in DNA Damage Response.
    Faridounnia M; Folkers GE; Boelens R
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
    Fisher LA; Samson L; Bessho T
    Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression.
    Yagi T; Katsuya A; Koyano A; Takebe H
    Mutagenesis; 1998 Nov; 13(6):595-9. PubMed ID: 9862190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease.
    Kuraoka I; Kobertz WR; Ariza RR; Biggerstaff M; Essigmann JM; Wood RD
    J Biol Chem; 2000 Aug; 275(34):26632-6. PubMed ID: 10882712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1.
    Wang C; Lambert MW
    Biochemistry; 2010 Jul; 49(26):5560-9. PubMed ID: 20518486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.
    Yamamoto KN; Kobayashi S; Tsuda M; Kurumizaka H; Takata M; Kono K; Jiricny J; Takeda S; Hirota K
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6492-6. PubMed ID: 21464321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3'-flap endonuclease XPF-ERCC1 promotes alternative end joining and chromosomal translocation during B cell class switching.
    Bai W; Zhu G; Xu J; Chen P; Meng F; Xue H; Chen C; Dong J
    Cell Rep; 2021 Sep; 36(13):109756. PubMed ID: 34592150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
    Gregg SQ; Robinson AR; Niedernhofer LJ
    DNA Repair (Amst); 2011 Jul; 10(7):781-91. PubMed ID: 21612988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures.
    Li S; Lu H; Wang Z; Hu Q; Wang H; Xiang R; Chiba T; Wu X
    iScience; 2019 Jun; 16():63-78. PubMed ID: 31153042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.